Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Merck & Co. Inc. | 28 | 1 | 2 | 0 | €118.60 | €124.92 | 5.331% |
| Novo Nordisk A/S ADR | 17 | 1 | 1 | 0 | €116.00 | €130.00 | 12.069% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €125.40 | €130.00 | 3.668% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €130.64 | €133.66 | 2.312% |
| Dexcom Inc. | 18 | 0 | 2 | 0 | €120.42 | €136.82 | 13.621% |
| Neurocrine Bioscience | 27 | 0 | 7 | 0 | €131.65 | €140.34 | 6.601% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €127.10 | €144.44 | 13.646% |
| Masimo Corp. | 7 | 1 | 2 | 0 | €128.20 | €147.62 | 15.145% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |
| Universal Health Services B | 9 | 3 | 1 | 1 | €156.00 | €159.70 | 2.375% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €140.10 | €165.00 | 17.773% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €151.12 | €174.43 | 15.427% |
| Krystal Biotech | 17 | 0 | 4 | 0 | €145.55 | €179.60 | 23.391% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Repligen Corp. | 13 | 0 | 1 | 0 | €155.15 | €184.76 | 19.085% |
| Jazz Pharmaceuticals plc | 23 | 0 | 4 | 0 | €102.00 | €184.92 | 81.294% |
| Johnson & Johnson | 32 | 1 | 3 | 0 | €137.98 | €196.74 | 42.583% |
| Zoetis Inc. A | 22 | 1 | 4 | 0 | €154.08 | €198.11 | 28.577% |
| EssilorLuxottica SA | 3 | 0 | 0 | 0 | €199.05 | €204.50 | 2.738% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €201.50 | €207.72 | 3.084% |
| Insulet Corp. | 14 | 0 | 1 | 0 | €163.80 | €215.54 | 31.586% |
| Alnylam Pharmace. | 35 | 0 | 3 | 0 | €140.35 | €228.30 | 62.665% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €188.00 | €237.94 | 26.564% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €189.00 | €247.18 | 30.783% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |